Xcout IntelAhammune Biosciences competitors & alternatives
The 12 closest competitors and alternatives to Ahammune Biosciences among drug discovery companies — ranked by similarity to what Ahammune Biosciences actually does, not by market-cap band.
Subscribe to see Ahammune Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Ahammune Biosciences
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Ahammune Biosciences at a glance
Ahammune Biosciences is a drug discovery company headquartered in India. Its most recent funding round, Series A, raised $5M in September 2024. Xcout tracks 10 named people at Ahammune Biosciences, including Dr. Parul Ganju (Co-founder, CEO, Board Member).
Ahammune Biosciences leadership
- Dr. Parul GanjuCo-founder, CEO, Board Member
- Dr Krishnamurthy NatarajanBoard Member, Co-founder
- Krishnamurthy Natarajanco-founder
- Parul Ganjuco-founder
- Dr Mahesh Kumar VermaAssistant Director, Biology
- Dr Sudhanand PrasadDirector, R&D
4 more named people on record for Ahammune Biosciences, with roles, board committees and tenure — see the full roster →
Ahammune Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Ahammune Biosciences competitors
Ranked by semantic similarity — how close each company is to Ahammune Biosciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Similar drug discovery company
Baseimmune is a biotechnology research company headquartered in London, United Kingdom, pioneering active immunotherapies. The company combines cutting-edge computational design with advanced protein engineering to develop next-generation vaccines.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Similar drug discovery company
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Similar drug discovery company
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Similar drug discovery company
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Similar drug discovery company
Aneira Pharma, Inc. is a privately held pharmaceutical company founded in 2008 with its headquarters in San Diego, California.
Similar drug discovery company
NXI Therapeutics AG is a biotech company based in Basel, Switzerland, focused on researching and developing selective immunosuppressive drugs and immunotherapies for autoimmune diseases and transplantation.
Similar drug discovery company
Salvina Therapeutics AG is a Swiss biotechnology research company that develops novel antibodies targeting TNF and TNF superfamily members to address inflammatory and autoimmune diseases. The privately held firm focuses on drug development approaches designed to improve safety and overcome efficacy barriers in these therapeutic areas.
Similar drug discovery company
Arkgen Bioscions is a South Korean immuno-oncology startup headquartered in Daejeon. The company recently raised a $6.67 million Series A funding round to advance its proprietary biotech research. It focuses on developing innovative biopharmaceutical treatments.
Similar drug discovery company
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Ahammune Biosciences and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ahammune Biosciencesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →